Immune-modulatory biomimetic nanoparticles: Advances in design, mechanisms, and nanomedicine applications

Somayeh Vandghanooni ¹ * , Parniya Kehtari ², Niloufar Ahdeno ²

Cited by CrossRef: 0

1- Yun D, Mu L, Liu J, Li C, Zhao S, Zhai Q, Sun H, Wu X, Shi K, Fan W. Biomimetic membrane-coated metal nanoplatforms for enhanced BBB penetration and targeted glioblastoma therapy. International Journal of Pharmaceutics: X. 2026;12:100612 [Crossref]

2- Feng M, Zhou H. Can Microneedle-Nanocarrier Platforms Deliver True Tolerogenic Immunotherapy for Psoriasis?. Vaccines. 2026;14(9):784 [Crossref]

3- Mirbolouk M, Sohail M. Leukocyte-mimicking nanoparticles for enhanced synovial targeting in autoimmune arthritis. International Journal of Pharmaceutics. 2026;700:127002 [Crossref]

4- Belkare C, Daware O. Darwinian nanomedicine: artificial intelligence-driven evolutionary drug delivery for adaptive and precision therapeutics. Drug Development and Industrial Pharmacy. 2026;:1 [Crossref]

5- Wang Y, Yu Y, Deng Q, Liu D, Liang X, Wang H, Zhou X, Ouyang J, Huang Y, Xiang L, Guan Z, Cheng B, Guo Z, Yang Z, Deng N, Zhong Q, Xie G, Li K, Wang Z, Li W, Song N. A Trojan horse nanoplatform overcoming delivery barriers for targeted gene immunotherapy of colorectal cancer. Front Bioeng Biotechnol. 2026;14 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Indexing and Abstracting Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2025): 19%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: CC BY-NC